Clinical Trial Update: Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating an intradermal electroporation-delivered DNA vaccine for colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Maria Liljefors | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED